Please login to the form below

I have forgotten my password

neuroblastoma

This page shows the latest neuroblastoma news and features for those working in and with pharma, biotech and healthcare.

ICR research shows how skin cancer cells invade new tissues

ICR research shows how skin cancer cells invade new tissues

The researchers say the gene is likely to be involved in the growth and spread of other cancer types, particularly neuroblastoma, which is a type of cancer that stems from nerve

Latest news

World Castleman Disease Day

Through their existing portfolio, which supports patients with iMCD, neuroblastoma, renal cell carcinoma (RCC) and oral mucositis (dryness of the mouth and throat) as a common side effect to anticancer therapy,
Y-mAbs files breakthrough neuroblastoma drug in US

as a therapy for patients with neuroblastoma, a rare type of cancer that mostly affects babies and young children. ... Another subset of 30 patients with relapsed neuroblastoma resistant to salvage therapy had a 36% two-year OFS rate and an ORR of 37%.
Orphan drugs from Biogen and Amicus win UK Prix Galien

In the same category, Qarziba, Eusa’s treatment for neuroblastoma, was highly commended.
Daily Brief: Takeda seals $62bn Shire deal, Autolus IPO, Gottlieb warning

effects. The company also recently presented data on a novel glycosphingolipid GD2-targeting programmed T cell product candidate in paediatric patients with neuroblastoma.
EUSA receives European green light for kidney cancer treatment Fotivda

field.”. The UK-based group has also recently received another EU approval for the rare cancer drug dinutuximab beta as a treatment for high-risk neuroblastoma patients over the age of

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Pharma deals in August 2015

408. United Therapeutics. AbbVie. Received on approval of Unituxin for neuroblastoma.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

PMHub

Add my company

Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Quick links